SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
1-Year Return
14.64%
This Quarter Return
+1.79%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$586M
AUM Growth
-$19.4M
(-3.2%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
17.48%
Holding
250
New
15
Increased
23
Reduced
114
Closed
18
Top Buys
| 1 |
Gambling.com
GAMB
|
$4.19M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
$3.78M |
| 3 |
AstraZeneca
AZN
|
$3.59M |
| 4 |
Global Payments
GPN
|
$3.3M |
| 5 |
Blue Owl Capital
OWL
|
$3.21M |
Top Sells
| 1 |
Wabtec
WAB
|
$4.27M |
| 2 |
AbbVie
ABBV
|
$3.78M |
| 3 |
Blackstone
BX
|
$3.33M |
| 4 |
GitLab
GTLB
|
$2.57M |
| 5 |
State Street
STT
|
$2.45M |
Sector Composition
| 1 | Technology | 36.08% |
| 2 | Industrials | 13.65% |
| 3 | Energy | 8.19% |
| 4 | Healthcare | 7.99% |
| 5 | Consumer Discretionary | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Berkshire Hathaway Class A
BRK.A
$1.08T
| $531K | 0.09% |
100
| – | – |
|
127
Coca-Cola
KO
$292B
| $519K | 0.09% |
9,270
+100
| +1% | +$5.6K |
|
128
CVS Health
CVS
$93.6B
| $477K | 0.08% |
6,833
| – | – |
|
129
Hershey
HSY
$37.6B
| $432K | 0.07% |
2,158
| – | – |
|
130
PepsiCo
PEP
$200B
| $421K | 0.07% |
2,487
+42
| +2% | +$7.12K |
|
131
Meta Platforms (Facebook)
META
$1.89T
| $421K | 0.07% |
1,401
| – | – |
|
132
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $384K | 0.07% |
7,695
-160
| -2% | -$7.98K |
|
133
Bank of America
BAC
$369B
| $383K | 0.07% |
14,000
-618
| -4% | -$16.9K |
|
134
McDonald's
MCD
$224B
| $368K | 0.06% |
1,396
+11
| +0.8% | +$2.9K |
|
135
Cisco
CSCO
$264B
| $365K | 0.06% |
6,792
| – | – |
|
136
Pfizer
PFE
$141B
| $361K | 0.06% |
10,877
| – | – |
|
137
Merck
MRK
$212B
| $356K | 0.06% |
3,459
+3
| +0.1% | +$309 |
|
|
138
Blackstone
BX
$133B
| $347K | 0.06% |
3,242
-31,104
| -91% | -$3.33M |
|
139
Mondelez International
MDLZ
$79.9B
| $342K | 0.06% |
4,925
| – | – |
|
140
SPDR NYSE Technology ETF
XNTK
$1.26B
| $341K | 0.06% |
2,079
+1
| +0% | +$164 |
|
141
Bristol-Myers Squibb
BMY
$96B
| $335K | 0.06% |
5,780
-1,000
| -15% | -$58K |
|
142
Oracle
ORCL
$654B
| $335K | 0.06% |
3,164
+147
| +5% | +$15.6K |
|
143
Texas Instruments
TXN
$171B
| $330K | 0.06% |
2,074
| – | – |
|
144
Walmart
WMT
$801B
| $315K | 0.05% |
5,907
| – | – |
|
145
Accenture
ACN
$159B
| $313K | 0.05% |
1,019
| – | – |
|
|
146
AbbVie
ABBV
$375B
| $309K | 0.05% |
2,070
-25,379
| -92% | -$3.78M |
|
147
Enterprise Products Partners
EPD
$68.6B
| $307K | 0.05% |
11,204
| – | – |
|
148
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $299K | 0.05% |
6,832
-54
| -0.8% | -$2.36K |
|
149
Johnson & Johnson
JNJ
$430B
| $297K | 0.05% |
1,906
-4
| -0.2% | -$623 |
|
150
Vanguard Intermediate-Term Bond ETF
BIV
$24.2B
| $281K | 0.05% |
3,697
+282
| +8% | +$21.4K |
|